These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 29084447)

  • 21. A macrophage-cell model of HIV latency reveals the unusual importance of the bromodomain axis.
    Kisaka JK; Rauch D; Griffith M; Kyei GB
    Virol J; 2024 Apr; 21(1):80. PubMed ID: 38581045
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Latent HIV-1 can be reactivated by cellular superinfection in a Tat-dependent manner, which can lead to the emergence of multidrug-resistant recombinant viruses.
    Donahue DA; Bastarache SM; Sloan RD; Wainberg MA
    J Virol; 2013 Sep; 87(17):9620-32. PubMed ID: 23804632
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of antigen presenting cells in the induction of HIV-1 latency in resting CD4(+) T-cells.
    Kumar NA; Cheong K; Powell DR; da Fonseca Pereira C; Anderson J; Evans VA; Lewin SR; Cameron PU
    Retrovirology; 2015 Sep; 12():76. PubMed ID: 26362311
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In Vitro Reactivation of Replication-Competent and Infectious HIV-1 by Histone Deacetylase Inhibitors.
    Banga R; Procopio FA; Cavassini M; Perreau M
    J Virol; 2016 Feb; 90(4):1858-71. PubMed ID: 26656693
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Influence of Biological Sex, Age, and HIV Status in an In Vitro Primary Cell Model of HIV Latency Using a CXCR4 Tropic Virus.
    Macedo AB; Resop RS; Martins LJ; Szaniawski MA; Sorensen ES; Spivak AM; Nixon DF; Jones RB; Planelles V; Bosque A
    AIDS Res Hum Retroviruses; 2018 Sep; 34(9):769-777. PubMed ID: 29926732
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dual role of prostratin in inhibition of infection and reactivation of human immunodeficiency virus from latency in primary blood lymphocytes and lymphoid tissue.
    Biancotto A; Grivel JC; Gondois-Rey F; Bettendroffer L; Vigne R; Brown S; Margolis LB; Hirsch I
    J Virol; 2004 Oct; 78(19):10507-15. PubMed ID: 15367617
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Understanding Factors That Modulate the Establishment of HIV Latency in Resting CD4+ T-Cells In Vitro.
    Anderson JL; Mota TM; Evans VA; Kumar N; Rezaei SD; Cheong K; Solomon A; Wightman F; Cameron PU; Lewin SR
    PLoS One; 2016; 11(7):e0158778. PubMed ID: 27383184
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Small-molecule screening using a human primary cell model of HIV latency identifies compounds that reverse latency without cellular activation.
    Yang HC; Xing S; Shan L; O'Connell K; Dinoso J; Shen A; Zhou Y; Shrum CK; Han Y; Liu JO; Zhang H; Margolick JB; Siliciano RF
    J Clin Invest; 2009 Nov; 119(11):3473-86. PubMed ID: 19805909
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Underlying mechanisms of HIV-1 latency.
    Romani B; Allahbakhshi E
    Virus Genes; 2017 Jun; 53(3):329-339. PubMed ID: 28258391
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Facilitation of hippocampal long-term potentiation and reactivation of latent HIV-1 via AMPK activation: Common mechanism of action linking learning, memory, and the potential eradication of HIV-1.
    Finley J
    Med Hypotheses; 2018 Jul; 116():61-73. PubMed ID: 29857913
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mechanisms of Endogenous HIV-1 Reactivation by Endocervical Epithelial Cells.
    Gornalusse GG; Valdez R; Fenkart G; Vojtech L; Fleming LM; Pandey U; Hughes SM; Levy CN; Dela Cruz EJ; Calienes FL; Kirby AC; Fialkow MF; Lentz GM; Wagoner J; Jing L; Koelle DM; Polyak SJ; Fredricks DN; McElrath MJ; Wald A; Hladik F
    J Virol; 2020 Apr; 94(9):. PubMed ID: 32051273
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HIV-1 latency and virus production from unintegrated genomes following direct infection of resting CD4 T cells.
    Chan CN; Trinité B; Lee CS; Mahajan S; Anand A; Wodarz D; Sabbaj S; Bansal A; Goepfert PA; Levy DN
    Retrovirology; 2016 Jan; 13():1. PubMed ID: 26728316
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Entry of Polarized Effector Cells into Quiescence Forces HIV Latency.
    Dobrowolski C; Valadkhan S; Graham AC; Shukla M; Ciuffi A; Telenti A; Karn J
    mBio; 2019 Mar; 10(2):. PubMed ID: 30914509
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vivo analysis of the effect of panobinostat on cell-associated HIV RNA and DNA levels and latent HIV infection.
    Tsai P; Wu G; Baker CE; Thayer WO; Spagnuolo RA; Sanchez R; Barrett S; Howell B; Margolis D; Hazuda DJ; Archin NM; Garcia JV
    Retrovirology; 2016 May; 13(1):36. PubMed ID: 27206407
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ultrasensitive HIV-1 p24 Assay Detects Single Infected Cells and Differences in Reservoir Induction by Latency Reversal Agents.
    Passaes CPB; Bruel T; Decalf J; David A; Angin M; Monceaux V; Muller-Trutwin M; Noel N; Bourdic K; Lambotte O; Albert ML; Duffy D; Schwartz O; Sáez-Cirión A
    J Virol; 2017 Mar; 91(6):. PubMed ID: 28077644
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lymphatic endothelial cells promote productive and latent HIV infection in resting CD4+ T cells.
    Schilthuis M; Verkaik S; Walhof M; Philipose A; Harlow O; Kamp D; Kim BR; Shen A
    Virol J; 2018 Oct; 15(1):152. PubMed ID: 30285810
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Stable Phenotypic Changes of the Host T Cells Are Essential to the Long-Term Stability of Latent HIV-1 Infection.
    Seu L; Sabbaj S; Duverger A; Wagner F; Anderson JC; Davies E; Wolschendorf F; Willey CD; Saag MS; Goepfert P; Kutsch O
    J Virol; 2015 Jul; 89(13):6656-72. PubMed ID: 25878110
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ex Vivo Bioactivity and HIV-1 Latency Reversal by Ingenol Dibenzoate and Panobinostat in Resting CD4(+) T Cells from Aviremic Patients.
    Spivak AM; Bosque A; Balch AH; Smyth D; Martins L; Planelles V
    Antimicrob Agents Chemother; 2015 Oct; 59(10):5984-91. PubMed ID: 26169416
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Naf1 Regulates HIV-1 Latency by Suppressing Viral Promoter-Driven Gene Expression in Primary CD4+ T Cells.
    Li C; Wang HB; Kuang WD; Ren XX; Song ST; Zhu HZ; Li Q; Xu LR; Guo HJ; Wu L; Wang JH
    J Virol; 2017 Jan; 91(1):. PubMed ID: 27795436
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combination of biological screening in a cellular model of viral latency and virtual screening identifies novel compounds that reactivate HIV-1.
    Gallastegui E; Marshall B; Vidal D; Sanchez-Duffhues G; Collado JA; Alvarez-Fernández C; Luque N; Terme JM; Gatell JM; Sánchez-Palomino S; Muñoz E; Mestres J; Verdin E; Jordan A
    J Virol; 2012 Apr; 86(7):3795-808. PubMed ID: 22258251
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.